Ignite Creation Date:
2024-05-06 @ 12:54 PM
Last Modification Date:
2024-10-26 @ 1:05 PM
Study NCT ID:
NCT03875495
Status:
TERMINATED
Last Update Posted:
2022-01-28
First Post:
2019-03-13
Brief Title:
A Phase III Study Evaluating Temferon in Multiple Myeloma Patients With Early Relapse After Front Line Therapy TEM-MM
Sponsor:
Genenta Science
Organization:
Genenta Science